Pharmaceuticals and vector-control programmes have greatly diminished the once-widespread disease, but sustained effort will ...
KLS-1 is under clinical development by Vector Vitale and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...
Convidecia is under clinical development by CanSino Biologics and currently in Phase III for Coronavirus Disease 2019 (COVID-19).
A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...
Purdue President Mung Chiang has announced the spring lineup for the Westwood Lecture Series, which provides an opportunity ...
With another year of adventures in eating out just beginning, let's take a look back at all the restaurants we lost in 2024.
CDMO National Resilience plots 120 layoffs at former bluebird bio facility in Research Triangle Park
Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...
The "Transfection Reagents & Equipment Market by Product, by Method, by Application, by End-User, and By Region" report has ...
The CDC called findings about bird flu mutations in a human case “concerning” but says the risk to the general public from the outbreak “remains low.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback